Reference
Jurcic P. Efficacy and safety of antivascular drug after anti-EGFR; Aflibercept after panitumumab, a clinical case. Libri Oncologici 45 (Suppl. 1): 55 (plus poster) abstr. P11, Jul 2017. Available from: URL: https://hrcak.srce.hr/185265 [abstract] -Croatia
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1748, 59 (2019). https://doi.org/10.1007/s40278-019-59975-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-59975-7